Open Session of Horizon 2020 Project TBMED: Open Innovation Test Beds (OITB) for Healthcare Product Development
8 July 2019 - 8 July 2019
Paris, France
With the entry into force of the new medical devices Regulation (Regulation (EU) 2017/745), Europe’s healthcare technology sector faces major challenges.
Europe’s MedTech sector is a highly innovative sector driven by small companies that, with the entry of the new regulation, will see their competitiveness and power of innovation at risk. The sector is driven by SMEs which represent 95% of the industry involved. At the same time, year after year, the number of patents filed in this sector exceeds the sum of patents in the pharmaceuticals and biotechnologies sector.
The European Commission has thus launched three new projects to support the MedTech industry and particularly SMEs to maintain a high level of innovation. This initiative is known as Open Innovation Test Beds (OITB) for the healthcare product sector. The aim of these test beds is to create platforms with a single entry point to provide services to innovative companies, covering the entire value chain from proof of concept to laboratory scale and up to the stage prior to obtaining the CE mark, which includes clinical trials.
TBMED is one of these three projects. Its focus is on the development of high-risk medical devices for the European market.
The Open Session will be held on July 8, 2019 from 3-6 PM in Paris and targets potential users of the Open Innovation Test Bed (OITB) for the healthcare product sector.
Inscription to the Open Session is free of charge, please register via email (j.jost@eurice.eu). The full programme is available on the TBMED website: http://tbmed.eu/events/tbmed-open-session
Europe’s MedTech sector is a highly innovative sector driven by small companies that, with the entry of the new regulation, will see their competitiveness and power of innovation at risk. The sector is driven by SMEs which represent 95% of the industry involved. At the same time, year after year, the number of patents filed in this sector exceeds the sum of patents in the pharmaceuticals and biotechnologies sector.
The European Commission has thus launched three new projects to support the MedTech industry and particularly SMEs to maintain a high level of innovation. This initiative is known as Open Innovation Test Beds (OITB) for the healthcare product sector. The aim of these test beds is to create platforms with a single entry point to provide services to innovative companies, covering the entire value chain from proof of concept to laboratory scale and up to the stage prior to obtaining the CE mark, which includes clinical trials.
TBMED is one of these three projects. Its focus is on the development of high-risk medical devices for the European market.
The Open Session will be held on July 8, 2019 from 3-6 PM in Paris and targets potential users of the Open Innovation Test Bed (OITB) for the healthcare product sector.
Inscription to the Open Session is free of charge, please register via email (j.jost@eurice.eu). The full programme is available on the TBMED website: http://tbmed.eu/events/tbmed-open-session
Keywords
open innovation test bed, medical devices, MedTech, OITB, healthcare